The 2026 Advanced Therapies Congress, set to take place from March 17-18 at ExCeL, London, is Europe's largest commercial cell and gene therapy conference and exhibition. This event is designed for industry leaders and senior executives driving the latest technologies and strategies in advanced therapies (ATMPs). The congress aims to inspire a community of 3,300 global executives, with over 300 speakers and 75 biotech start-ups over two days.

The congress covers the entire value chain of cell and gene therapy development, including forward-thinking pharmaceutical companies, biotech firms, researchers, clinicians, academics, health technology assessors (HTAs), payers, and regulators. Notable speakers include Eric David from Gene Therapy BridgeBio Gene Therapy, Jordan Schecter from Johnson & Johnson, and Oluwayemisi Corinaldi from Spark Therapeutics.

Exhibitors at the event include 50 leading solution providers catering to all stages of cell and gene therapy development. Attendees can network with thousands of experts over 12+ hours of built-in one-on-one networking sessions. The event offers a unique opportunity to connect with industry leaders and gain insights into the latest advancements in advanced therapies.

The congress features eight tracks of content over two days, providing comprehensive coverage of the ATMP industry. Attendees can expect to learn about innovative strategies and technologies shaping the future of cell and gene therapies. The event also includes networking opportunities that foster collaboration among industry professionals.

With tickets available now until April 11th, interested individuals can register to attend this premier event in the field of advanced therapies. Whether you are a sponsor or exhibitor looking to showcase your products or a participant eager to learn about the latest developments in ATMPs, this congress offers a wealth of information and networking opportunities. Join us in London on March 17-18 for an unparalleled experience in advanced therapies.